IMPLEMENTATION AND STANDARDIZATION OF OUTPATIENT BISPECIFIC HIGH RISK IMMUNOTHERAPY REGIMENS.
Significance & Background: At a Comprehensive Cancer Center (CCC) serving 64,000 patients annually Bispecifics Immunotherapies have played a major role in treatment a variety of diagnoses. This innovative modality evaluation revealed critical gaps in administration, monitoring, and toxicity manageme...
| Publicado en: | Oncology Nursing Forum Vol. 53; no. 2; pp. 20 - 22 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Oncology Nursing Society
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |